215 related articles for article (PubMed ID: 29305275)
61. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
62. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
[TBL] [Abstract][Full Text] [Related]
63. Stroke after adenotonsillectomy in patients with undiagnosed moyamoya syndrome.
Ahn AK; Honeybrook A; Jordan LC; Singer RJ; Tylor DA
JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1061-4. PubMed ID: 25257069
[TBL] [Abstract][Full Text] [Related]
64. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
Jang DK; Huh PW; Lee KS
J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
[TBL] [Abstract][Full Text] [Related]
65. The disease presentation of Moyamoya angiopathy in Eastern India.
Das S; Dubey S; Acharya M; Ghosh R; Chatterjee S; Hazra A; Lahiri D; Segupta S; Chatterjee S; Das G; Sarkar N; Ray BK; Kraemer M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104957. PubMed ID: 32689603
[TBL] [Abstract][Full Text] [Related]
66. Non-atherosclerotic vascular disease in the young.
Camilo O; Goldstein LB
J Thromb Thrombolysis; 2005 Oct; 20(2):93-103. PubMed ID: 16205858
[TBL] [Abstract][Full Text] [Related]
67. Novel insights into symptomatology of moyamoya disease in pediatric patients: survey of symptoms suggestive of orthostatic intolerance.
Uchino H; Kazumata K; Ito M; Nakayama N; Houkin K
J Neurosurg Pediatr; 2017 Nov; 20(5):485-488. PubMed ID: 28862519
[TBL] [Abstract][Full Text] [Related]
68. [Moyamoya disease: Diagnosis, clinical features, evolution and treatment in 10 patients].
Blanc C; Janoura S; Pallot C; Mettey L; Bardin F; Ricolfi F; Chavent A; Osseby GV; Giroud M; Béjot Y
Rev Neurol (Paris); 2015 Jan; 171(1):58-64. PubMed ID: 25555852
[TBL] [Abstract][Full Text] [Related]
69. Risk Factors for Newly Developed Cerebral Infarction After Surgical Revascularization for Adults with Moyamoya Disease.
Park W; Ahn JS; Lee HS; Park JC; Kwun BD
World Neurosurg; 2016 Aug; 92():65-73. PubMed ID: 27020972
[TBL] [Abstract][Full Text] [Related]
70. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine.
Marcinkevicius E; Liutkus D; Gvazdaitis A
Medicina (Kaunas); 2006; 42(2):130-6. PubMed ID: 16528129
[TBL] [Abstract][Full Text] [Related]
71. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
72. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.
Hirai S; Inaji M; Tanaka Y; Hara S; Nariai T; Maehara T
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2814-2820. PubMed ID: 28778721
[TBL] [Abstract][Full Text] [Related]
73. Moyamoya disease in China: its clinical features and outcomes.
Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
[TBL] [Abstract][Full Text] [Related]
74. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India.
Sundaram S; Sylaja PN; Menon G; Sudhir J; Jayadevan ER; Sukumaran S; Sreedharan SE; Sarma S
J Neurol Sci; 2014 Jan; 336(1-2):99-102. PubMed ID: 24183032
[TBL] [Abstract][Full Text] [Related]
75. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
[TBL] [Abstract][Full Text] [Related]
76. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
77. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
[TBL] [Abstract][Full Text] [Related]
78. [Moyamoya disease in childhood].
Velkey I; Lombay B
Orv Hetil; 1991 Oct; 132(41):2271-3. PubMed ID: 1945363
[TBL] [Abstract][Full Text] [Related]
79. A nationwide survey on unilateral moyamoya disease in Japan.
Hayashi K; Horie N; Izumo T; Nagata I
Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
[TBL] [Abstract][Full Text] [Related]
80. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
Fukui M
Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S238-40. PubMed ID: 9409446
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
